Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T04831 | Target Info | |||
Target Name | Tyrosine-protein kinase EIF2AK2 (p68) | ||||
Synonyms | p68 kinase; Proteinkinase RNA-activated; Interferon-inducible RNA-dependent protein kinase p68; Interferon-induced, double-stranded RNA-activated protein kinase p68 | ||||
Target Type | Patented-recorded Target | ||||
Gene Name | EIF2AK2 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acid anhydride hydrolases | [+] 2 Acid anhydride hydrolases | + | |||
Interacting Protein Name | ATP-dependent RNA helicase A (DHX9) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DDX9; LKP; NDH2; NDHII; RHA | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Affinity Capture-Western | [1] | |||
4 | Biochemical Activity | [1] | |||
5 | Reconstituted Complex | [2] | |||
Interacting Protein Name | ATP-dependent RNA helicase DHX30 (DHX30) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DDX30; RETCOR | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Reconstituted Complex | [2] | |||
Eukaryotic initiation factors | [+] 1 Eukaryotic initiation factors | + | |||
Interacting Protein Name | Eukaryotic translation initiation factor 2 subunit 1 (EIF2S1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | EIF.2; EIF.2A; EIF.2alpha; EIF2; EIF2A | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [4] | |||
2 | Biochemical Activity | [5] | |||
3 | Biochemical Activity | [6] | |||
4 | Reconstituted Complex | [7] | |||
5 | Reconstituted Complex | [6] | |||
Heat shock proteins | [+] 1 Heat shock proteins | + | |||
Interacting Target Name | Heat shock protein 90 alpha (HSP90A) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Renal carcinoma antigen NY-REN-38; LPS-associated protein 2; Lipopolysaccharide-associated protein 2; LAP-2; HSPCA; HSPC1; HSP90A; HSP86; HSP 86; Heat shock protein HSP 90-alpha; Heat shock 86 kDa | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Luminescence | [8] | |||
2 | Affinity Capture-Western | [9] | |||
Pore-forming toxins | [+] 1 Pore-forming toxins | + | |||
Interacting Target Name | Cellular tumor antigen p53 (TP53) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor suppressor p53; Phosphoprotein p53; P53; Antigen NY-CO-13 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [10] | |||
2 | Affinity Capture-Western | [11] | |||
3 | Biochemical Activity | [10] | |||
4 | Reconstituted Complex | [10] | |||
Transcription regulators | [+] 1 Transcription regulators | + | |||
Interacting Target Name | Signal transducer and activator of transcription 1 (STAT1) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor ISGF-3 components p91/p84; STAT-1; Signal transducers and activators of transcription factor; Signal transducer and activator of transcription 1-alpha/beta; P91 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [12] | |||
2 | Reconstituted Complex | [13] | |||
Other proteins | [+] 4 Other proteins | + | |||
Interacting Protein Name | Interleukin enhancer-binding factor 3 (ILF3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CBTF; DRBF; DRBP76; MMP4; MPHOSPH4; MPP4; NF.AT.90; NF110; NF110b; NF90; NF90a; NF90b; NFAR; NFAR.1; NFAR2; TCP110; TCP80 | ||||
Evidence Score (E-score) | 11 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [14] | |||
2 | Affinity Capture-Western | [15] | |||
3 | Biochemical Activity | [14] | |||
4 | Biochemical Activity | [15] | |||
5 | Biochemical Activity | [16] | |||
6 | Biochemical Activity | [17] | |||
7 | Reconstituted Complex | [14] | |||
8 | Reconstituted Complex | [15] | |||
9 | Reconstituted Complex | [17] | |||
10 | Yeast two hybrid | [14] | |||
11 | Yeast two hybrid | [17] | |||
Interacting Target Name | Nucleophosmin (NPM1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Numatrin; Nucleolar protein NO38; Nucleolar phosphoprotein B23; NPM | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [6] | |||
2 | Affinity Capture-Western | [18] | |||
3 | Affinity Capture-Western | [6] | |||
4 | Biochemical Activity | [6] | |||
5 | Reconstituted Complex | [6] | |||
Interacting Protein Name | RISC-loading complex subunit TARBP2 (TARBP2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | LOQS; TRBP; TRBP1; TRBP2 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Far Western | [19] | |||
3 | Reconstituted Complex | [2] | |||
4 | Yeast two hybrid | [19] | |||
5 | Yeast two hybrid | [20] | |||
Interacting Protein Name | PKR-associated protein X (PRKRA) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DYT16; PACT; RAX | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Reconstituted Complex | [21] | |||
4 | Yeast two hybrid | [22] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | An antiviral response directed by PKR phosphorylation of the RNA helicase A. PLoS Pathog. 2009 Feb;5(2):e1000311. | ||||
REF 2 | Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity. 2011 Sep 23;35(3):426-40. | ||||
REF 3 | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. Nat Methods. 2013 Apr;10(4):307-14. | ||||
REF 4 | Interferons induce tyrosine phosphorylation of the eIF2alpha kinase PKR through activation of Jak1 and Tyk2. EMBO Rep. 2007 Mar;8(3):265-70. | ||||
REF 5 | Requirement for kinase-induced conformational change in eukaryotic initiation factor 2alpha (eIF2alpha) restricts phosphorylation of Ser51. Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4316-21. | ||||
REF 6 | Nucleophosmin interacts with and inhibits the catalytic function of eukaryotic initiation factor 2 kinase PKR. J Biol Chem. 2003 Oct 24;278(43):41709-17. | ||||
REF 7 | Distal recognition sites in substrates are required for efficient phosphorylation by the cAMP-dependent protein kinase. Genetics. 2009 Jun;182(2):529-39. | ||||
REF 8 | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. Cell. 2012 Aug 31;150(5):987-1001. | ||||
REF 9 | The Hsp90 chaperone complex is both a facilitator and a repressor of the dsRNA-dependent kinase PKR. EMBO J. 2001 Jul 16;20(14):3771-80. | ||||
REF 10 | The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro. Oncogene. 1999 Apr 29;18(17):2690-702. | ||||
REF 11 | Evidence of molecular links between PKR and mTOR signalling pathways in Abeta neurotoxicity: role of p53, Redd1 and TSC2. Neurobiol Dis. 2009 Oct;36(1):151-61. | ||||
REF 12 | Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO J. 1997 Mar 17;16(6):1291-304. | ||||
REF 13 | Enhanced antiviral and antiproliferative properties of a STAT1 mutant unable to interact with the protein kinase PKR. J Biol Chem. 2001 Apr 27;276(17):13727-37. | ||||
REF 14 | Characterization of two evolutionarily conserved, alternatively spliced nuclear phosphoproteins, NFAR-1 and -2, that function in mRNA processing and interact with the double-stranded RNA-dependent protein kinase, PKR. J Biol Chem. 2001 Aug 24;276(34):32300-12. | ||||
REF 15 | Nuclear factor 90 is a substrate and regulator of the eukaryotic initiation factor 2 kinase double-stranded RNA-activated protein kinase. J Biol Chem. 2001 Aug 31;276(35):32522-30. | ||||
REF 16 | Nuclear factor-90 of activated T-cells: A double-stranded RNA-binding protein and substrate for the double-stranded RNA-dependent protein kinase, PKR. Biochemistry. 1999 May 11;38(19):6361-8. | ||||
REF 17 | DRBP76, a double-stranded RNA-binding nuclear protein, is phosphorylated by the interferon-induced protein kinase, PKR. J Biol Chem. 1999 Jul 16;274(29):20432-7. | ||||
REF 18 | Antiviral action of the tumor suppressor ARF. EMBO J. 2006 Sep 20;25(18):4284-92. | ||||
REF 19 | Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo. Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9445-9. | ||||
REF 20 | Two dimerization domains in the trans-activation response RNA-binding protein (TRBP) individually reverse the protein kinase R inhibition of HIV-1 long terminal repeat expression. J Biol Chem. 2001 Sep 7;276(36):33899-905. | ||||
REF 21 | The C-terminal, third conserved motif of the protein activator PACT plays an essential role in the activation of double-stranded-RNA-dependent protein kinase (PKR). Biochem J. 2002 Aug 15;366(Pt 1):175-86. | ||||
REF 22 | PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J. 1998 Aug 3;17(15):4379-90. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.